Company: Patient Derived Models Center, Dana-Farber Cancer Institute
Job title: Associate Director
Kin-Hoe Chow, Ph.D., is the Associate Director of the Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute (DFCI). He is leading the strategic planning and collaboration with researchers and industry partners to advance model science and leverage patient model diversity for improved basic research and clinical trials predictions. Through collaboration with major disease groups in the DFCI/BWH/BCH Cancer Centers, he has advanced specific methodologies for patient derived cell lines (PDCLs), patient derived xenografts (PDXs), and acute cell sensitivity testing of freshly isolated cancer cells to drugs (AST). A distributable inventory of 900+ patient derived models of hematologic and solid tumors generated at DFCI can now be accessed by academic and industrial researchers worldwide with established infrastructural and staffing supports to help researchers to select the best cancer models for their research studies.